The MENA syringes and cannulas market is poised for remarkable growth, with sales expected to rise from an estimated USD 1,592.2 million in 2024 to USD 2,824.7 million by 2034. This surge reflects a robust compound annual growth rate (CAGR) of 5.9% over the forecast period, driven by the escalating demand for essential healthcare devices across the region.
In 2023, syringes alone generated an impressive revenue of USD 1,108.1 million, highlighting their vital role in medical treatments. The market is anticipated to continue its upward trajectory with a year-over-year growth rate of 5.9% in 2024. Syringes are expected to maintain their dominance in the MENA market, capturing over 73.7% of the market share. This growth is largely attributed to the rising prevalence of chronic diseases such as diabetes and cancer, which necessitate regular injections and treatment.
The increasing adoption of injectable drugs for a variety of medical conditions further supports the expansion of the syringes segment. Several factors are propelling the growth of the MENA syringes and cannulas market, including rapid urbanization, escalating healthcare spending, and the growing integration of advanced devices featuring enhanced safety attributes. These advancements are critical in addressing the region’s healthcare challenges and improving patient outcomes.
“We are witnessing a significant shift in the healthcare landscape in MENA, with a marked increase in the demand for syringes and cannulas,” said FMI. “The growth is driven by various factors, including the rising incidence of chronic diseases, improved healthcare infrastructure, and advancements in medical technology. We are committed to meeting this demand and contributing to the region’s health and well-being.”
Key Takeaways: Syringes & Cannula Market in MENA
- The MENA syringes & cannula market is projected to grow steadily, with a CAGR of 5.9% from 2024 to 2034.
- Sales are expected to increase from USD 1.59 billion in 2024 to USD 2.82 billion by 2034.
- The market experienced a CAGR of 4.7% during the historical period (2019-2023).
- Sales increased from USD 1.18 billion in 2019 to USD 1.50 billion in 2023.
- Saudi Arabia Holds the largest market share (15.8%) and is expected to maintain its position.
- Turkey Also holds a significant market share (12.4%) and is projected to grow at a steady pace.
- UAE, Egypt, Morocco, Qatar, and Kuwait: These countries are expected to experience strong growth rates during the forecast period.
Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!
Competitive Landscape:
Key players in the syringes and cannula market are focusing on expanding their geographical reach by enhancing their direct sales channels and distributor networks. They are also pursuing strategic collaborations to launch new products.
Recent Developments in the MENA Syringes and Cannula Market:
In November 2021, Diabeloop SA, a leader in therapeutic AI, partnered with Terumo Corporation to develop Automated Insulin Delivery (AID) solutions for Japan and Europe, with plans to extend their offerings to the MENA region.
In the same month, Becton Dickinson & Company increased their manufacturing capacity in Spain to bolster their presence in Europe and strengthen their distribution network in the MENA region.
Key Players:
- Ambu A/S
- Becton, Dickinson, and Company
- Cardinal Health
- B. Braun Medical Inc.
- Medline Industries Inc.
- Nipro Corporation
- Terumo Corporation
- Hindustan Syringes & Medical Devices Ltd.
- Schott Kaisha Private Limited
- Edwards Lifesciences Corporation
- Abu Dhabi National Industrial Projects Company
- Middle East Medical
- Medtronic Plc.
- The 3M Company
- Honeywell International Inc.
- Kimberly-Clark Corporation
- DuPont de Nemours, Inc.
- Top Glove Corporation Bhd
- Ansell Limited
- Hartalega Holdings Berhad
Key Segments of Reconditioned IBC Industry:
By Product:
In terms of product, the industry is divided into syringes (disposable hypodermic syringes, auto disposable syringes, safety syringes, prefilled syringes, insulin syringes), and cannula (neonatal cannula, straight cannula, winged cannula, cannula with wings & port, cannula with integrated stop cock, nasal cannula)
By Usage:
In terms of usage, the industry is segregated into reusable and disposable.
By Distribution Channel:
The industry is classified distribution channel as institutional sales (hospitals, ambulatory surgical centres, office-based clinics, skilled nursing facilities & long term care centres, diagnostic laboratories and academic and research institutions), retail sales (retail pharmacies, drug stores, retail stores {hypermarket/supermarket}, online sales)
By Region:
Key countries of MENA, including Algeria, Iran, Israel, Egypt, UAE, Saudi Arabia, Morocco, Kuwait, Qatar, Turkey, and Rest of MENA have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
